ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act By Ogkologos - June 11, 2025 677 0 Facebook Twitter Google+ Pinterest WhatsApp Ensuring equitable access to cancer treatments remains central to EU health security efforts Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Five Questions With…Keon. June 16, 2022 Immunotherapy Combination Most Effective as Initial Treatment for BRAF+ Melanoma December 17, 2021 For Early-Stage Cervical Cancer, Minimally Invasive Surgery Declining May 25, 2021 New study identifies how obesity may increase the risk of developing... April 19, 2022 Load more HOT NEWS A Blood-Based, Multigenomic Signature is an Effective Diagnostic and Has Clinical... Tarlatamab Shows Promise for Some People with Small Cell Lung Cancer Reflections from our chief clinician: The essential role of our research... Though the Pandemic Has Slowed, Many Are Still Struggling to Put...
